M.Pharm

Torrent Pharma, the flagship company of Torrent Group, is ranked amongst the top pharma companies of India. It is a dominant player in the therapeutic areas of cardiovascular (CV) and central nervous system (CNS) and has achieved significant presence in gastro-intestina, diabetology, anti-infective and pain management segments. Torrent Pharma has a strong international presence spanning over 70 countries with over 1200 product registrations.

Encube is an integrated pharmaceutical company dedicated only to topical formulations viz. creams, ointments, gels, lotions, and solutions, with 24 years of formidable experience in contract development and manufacturing. Shri Mehul Shah, Promoter and Managing Director, incorporated Encube, on Sep 7, 1995, and commenced commercial operations on Mar 4, 1998.

The origins of the Advanced Centre for Treatment, Research and Education in Cancer (ACTREC) are rooted in the Indian Cancer Research Centre (ICRC), which was established in 1952 in Parel, Mumbai, under the purview of the Ministry of Health, Government of India.

Assam University came into existence in 1994 after enactment of the Assam (Central) University Act 1989. Through its pursuit, Assam University is in the process of making itself an institute of excellence.  Assam University main campus is situated at Dargakona, about 20 kms away from Silchar. The campus is set amid sprawling hillocks and typical landscape of north east. The campus is spread over 600 acres and provide an ideal environment for the researchers, students and the people interested in academic excellence.

The National Institute of Pharmaceutical Education and Research (NIPER) is the first Institute of its kind to be set up at in the State of Bihar in the year 2007. It is an autonomous institution of national importance, established under the aegis of Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Govt. of India under NIPER Act 1998 at Hajipur in Vaishali District of Bihar.

Piramal Group has interests in a portfolio of businesses including financial services (Piramal Enterprises Limited), pharmaceuticals (Piramal Pharma Limited), and real estate (Piramal Realty). With operations in 30 countries and brand presence in over 100 markets, the Group’s turnover is ~1.9 billion usd in FY 2022. Driven by its core values, the Group pursues inclusive growth, while adhering to ethical and value-driven practices.

Intas is one of the leading multinational pharmaceutical formulation development, manufacturing and marketing companies in the world. Today, Intas is present in more than 85 countries worldwide and is growing at 20% CAGR. Around 70% of its revenues come from the international markets, particularly the highly regulated markets of EU and US. At Intas, every day and everyone works to create a world of good health, happinessand hope.

Finecure Pharmaceuticals Limited and its subsidiaries are leading manufacturers and marketers of Pharmaceutical formulations and Nutraceuticals in several therapeutic segments in dosage forms of Tablets, Capsules, Oral Liquids, Dry Syrup, Powders, Injections and Sachet. Finecure runs on principles of quality management systems as guided by its mission, vision, values and ethics which act as role models. The company is moving towards a long term goal of discovery, development, manufacture, marketing and sales of novel drugs.

Mepro Pharmaceuticals Pvt Ltd., is a privately owned pharmaceutical company with over 5 decades of experience in manufacturing of tablets, capsules, creams/ointments and sterile injectable. Mepro is approved by various regulatory authorities as UK-MHRA, EUGMP, and PIC's nations besides governing bodies of many other countries.

Mepro is looking for ambitious, energetic and dynamic candidates as per the following positions. (EU-GMP APPROVED)